Repligen Corp
RGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000730272
In the last 90 days, Repligen Corp insiders filed 0 open-market purchases and 5 sales; 481 institutions reported holding it in 13F filings for Q2 2026, worth $9.00B in total; 3 superinvestors hold it, including Maverick Capital and Duquesne Family Office.
13F holders, Q4 2021
Institutional positions in Repligen Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 508
- +31 vs. Q3 2021
- Shares held
- 47.3M
- +98.7K (+0.2%) vs. Q3 2021
- Total value
- $12.5B
- −$1.12B (−8.2%) vs. Q3 2021
- New holders
- 86
- 156 more added
- Sold out
- 55
- 181 more reduced
4 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 481 | $9.00B |
| Q1 2026 | 445 | $7.75B |
| Q4 2025 | 475 | $10.2B |
| Q3 2025 | 453 | $8.00B |
| Q2 2025 | 446 | $7.22B |
| Q1 2025 | 441 | $7.33B |
| Q4 2024 | 431 | $8.09B |
| Q3 2024 | 445 | $8.25B |
| Q2 2024 | 455 | $7.06B |
| Q1 2024 | 487 | $10.3B |
| Q4 2023 | 467 | $10.4B |
| Q3 2023 | 440 | $9.08B |
| Q2 2023 | 448 | $7.74B |
| Q1 2023 | 448 | $9.06B |
| Q4 2022 | 443 | $9.06B |
| Q3 2022 | 434 | $9.56B |
| Q2 2022 | 406 | $8.17B |
| Q1 2022 | 450 | $9.15B |
| Q4 2021 | 508 | $12.5B |
| Q3 2021 | 481 | $13.6B |
| Q2 2021 | 430 | $9.28B |
| Q1 2021 | 459 | $8.88B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Repligen Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameriprise Financial Inc | 1,198,675 | $317.5M | 0.09% | +479,994+66.8% | Added |
| Fred Alger Management, LLC | 1,218,642 | $322.7M | 0.81% | −355,356−22.6% | Reduced |
| State Street Corp | 1,347,371 | $356.8M | 0.02% | +34,757+2.6% | Added |
| WCM Investment Management, LLC | 1,361,909 | $360.7M | 0.81% | +51,297+3.9% | Added |
| Invesco Ltd. | 1,690,607 | $447.7M | 0.11% | −446,775−20.9% | Reduced |
| Price T Rowe Associates Inc | 3,042,655 | $805.8M | 0.07% | +737,206+32.0% | Added |
| Vanguard Group Inc | 4,912,769 | $1.30B | 0.03% | +41,509+0.9% | Added |
| BlackRock Inc. | 5,189,189 | $1.37B | 0.04% | −34,281−0.7% | Reduced |
| Berkshire Capital Holdings Inc | 0 | $0 | 0.00% | −51,520−100.0% | Sold out |
| Stanley-Laman Group, Ltd. | 0 | $0 | 0.00% | −41,069−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −27,989−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −27,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −14,724−100.0% | Sold out |
| SV Health Investors, LLC | 0 | $0 | 0.00% | −14,541−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −14,064−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −8,773−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −7,797−100.0% | Sold out |
| Samson Rock Capital LLP | 0 | $0 | 0.00% | −6,686−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −5,249−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −3,914−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −3,573−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −3,473−100.0% | Sold out |
| Summit Global Investments | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| AMP Capital Investors Ltd | 0 | $0 | 0.00% | −2,854−100.0% | Sold out |
| Kemnay Advisory Services Inc. | 0 | $0 | 0.00% | −2,676−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −2,371−100.0% | Sold out |
| O'Neil Global Advisors, Inc. | 0 | $0 | 0.00% | −1,658−100.0% | Sold out |
| CastleArk Alternatives, LLC | 0 | $0 | 0.00% | −1,470−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −1,414−100.0% | Sold out |
| Ambassador Advisors, LLC | 0 | $0 | 0.00% | −1,186−100.0% | Sold out |
| D.A. Davidson & Co. | 0 | $0 | 0.00% | −1,160−100.0% | Sold out |
| Colony Group LLC | 0 | $0 | 0.00% | −1,106−100.0% | Sold out |
| Marco Investment Management LLC | 0 | $0 | 0.00% | −970−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −885−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −883−100.0% | Sold out |
| Vicus Capital | 0 | $0 | 0.00% | −876−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −849−100.0% | Sold out |
| Inverness Counsel LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Hardy Reed LLC | 0 | $0 | 0.00% | −790−100.0% | Sold out |
| Cedar Brook Financial Partners, LLC | 0 | $0 | 0.00% | −763−100.0% | Sold out |
| Bridgewater Associates, LP | 0 | $0 | 0.00% | −736−100.0% | Sold out |
| Intellectus Partners, LLC | 0 | $0 | 0.00% | −735−100.0% | Sold out |
| Claret Asset Management Corp | 0 | $0 | 0.00% | −732−100.0% | Sold out |
| First Foundation Advisors | 0 | $0 | 0.00% | −710−100.0% | Sold out |
| Moody National Bank Trust Division | 0 | $0 | 0.00% | −699−100.0% | Sold out |
| Game Plan Financial Advisors, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Peak Financial Management, Inc. | 0 | $0 | 0.00% | −693−100.0% | Sold out |
| Centaurus Financial, Inc. | 0 | $0 | 0.00% | −585−100.0% | Sold out |
| Liberty Wealth Management LLC | 0 | $0 | 0.00% | −268−100.0% | Sold out |
| South Dakota Investment Council | 0 | $0 | 0.00% | −258−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Rational Advisors LLC | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −141−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Accel Wealth Management | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Trustcore Financial Services, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Kowal Investment Group, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| World Asset Management Inc | – | – | – | – | Not filed |
| BBVA USA | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |